SUPPLY OF ANTIMALARIAL MEDICINESClosed

Overview

Supply of antimalarial medicines for the Kenyan public-health program, procured by KEMSA through an Open International Tender. The procurement targets pharmaceutical suppliers and manufacturers (and authorized distributors) with relevant approvals to bid for the supply of antimalarial medicines; documents and registration are via KEMSA/PPIP portals, with a bid security requirement and local-content rules for foreign bidders.

Requirements

• Eligibility and integrity as per ITT: no debarment, no conflicts of interest, allow JV with joint liability.
• Local-content: foreign bidders must source at least 40% of inputs from Kenyan suppliers/contractors.
• Documentation: Form of Tender; Price Schedules; Tender Security (KES 3,000,000) or equivalent; Manufacturer’s Authorization if not manufacturing in Kenya; Joint Venture Agreement if applicable; tax compliance clearance; registration of goods in Kenya.
• Technical and compliance: evidence of conformity to Section VII Schedule of Requirements; product registration in Kenya; service/representation for foreign bidders if not locally present.
• Rules: adherence to Public Procurement and Asset Disposal Act 2015; PPRA guidelines; currency and pricing rules for international bidders.

How to Apply

• Obtain documents: from KEMSA website www.kemsa.go.ke and PPIP Portal tenders.go.ke (free of charge). Register at Procurement Office or via procure@kemsa.go.ke / procurement.program@kemsa.go.ke. (see SUPPLY OF ANTIMALARIAL MEDICINES.pdf)
• Key documents to submit: Form of Tender; Price Schedules; Tender Security (or Tender-Securing Declaration); Manufacturer’s Authorization; Joint Venture documents if applicable; evidence of eligibility and registration of Goods in Kenya.
• Submission details: sealed tenders in a single outer envelope, with an “ORIGINAL” and “COPIES” sub-envelopes, to Tender Box No.1 at KEMSA Embakasi, Nairobi, on or before 28 October 2026 (time per ITT; typically 10:00 a.m.). Late bids are not accepted. Electronic submission is possible if permitted by the Tender Data Sheet.
• Pre-bid conference: 13 October 2026 at 10:00, KEMSA Tender Opening Hall (optional unless stated).
• Bid security and QR-based electronic securities: acceptable forms include bank guarantee or insurance-backed security; electronic securities may be QR-scanned (PPRA Circular 01/2023).
• Clarifications: written requests in line with ITT deadlines; responses to all bidders (see ITT 7).
• Source documents: INVITATION TO TENDER and REGISTRATION FORM within SUPPLY OF ANTIMALARIAL MEDICINES (see attached document).